This response was completely blocked by anti-IL-4Rα treatment at both mRNA and protein levels, an observation in line with our previous findings in BECs from chronic obstructive pulmonary disease (COPD) patients (23). The gene discussed is IL4R; the disease is chronic obstructive pulmonary disease.